Cervolve is a Montreal-based platform biotech dedicated to transforming how we understand and treat neurodegenerative disease. By integrating human genetics, machine learning, and systems biology, we are building a lipid AI platform to uncover the mechanistic underpinnings of lipid metabolism in the brain and translate them into therapeutically actionable insights. 

Our platform integrates diverse data modalities across biological scales, from single-cell data to whole-brain imaging, to define lipid pathways that drive neurodegenerative risk and disease progression. Our approach embraces the complexity of the brain, recognizing lipid metabolism as a central yet underexplored axis of disease biology. 

Anchored in data and driven by discovery, Cervolve’s mission is to identify differentiated mechanisms and first-in-class targets with the potential to redefine outcomes for patients affected by neurodegenerative disorders.

Cervolve

Org chart

Teams

Offices